Fenestra Launch
MediLumine’s Fenestra® imaging agents for preclinical computed tomography will be presented at the upcoming WMIC.
Fenestra® LC and Fenestra® VC imaging agents are used for a wide array of applications in preclinical computed tomography and molecular imaging. These hepatocyte selective nanoemulsions help to enable co-registration of soft tissue CT data for multimodal molecular imaging, quantification of metastatic tumor burdens, 4D imaging for characterization of murine cardiovascular disease and quantitative assessments of anti-angiogenic therapies.